Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1995-5-10
|
pubmed:abstractText |
Serotonin (5-HT) is thought to play an important role in the seizures of El mice because the seizure threshold of El mice correlates with the 5-HT concentration in the central nervous system. In this study, the anticonvulsant effect of a 5-HT reuptake blocker, citalopram, was evaluated behaviorally and biochemically. El mouse convulsions were inhibited by chronic administration of citalopram (80 mg/kg/day, p.o. for 2 weeks), but were not inhibited by acute administration of citalopram (80 mg/kg, i.p., 2 h after single injection). Both chronic and acute administration of citalopram decreased the concentration of 5-hydroxyindolacetic acid in the brain, whereas the concentration of 5-HT was not changed by treatment with citalopram. Tryptophan hydroxylase activity was not different between the citalopram and control groups, although the monoamine oxydase-A activity was lowered by chronic administration of citalopram. These findings suggest that both acute and chronic administration of citalopram depresses the 5-HT turnover rate, however chronic administration is necessary to inhibit El mouse convulsions.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anticonvulsants,
http://linkedlifedata.com/resource/pubmed/chemical/Citalopram,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxyindoleacetic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Monoamine Oxidase,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin,
http://linkedlifedata.com/resource/pubmed/chemical/Tryptophan Hydroxylase
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0386-300X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
48
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
311-6
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:7535969-Administration, Oral,
pubmed-meshheading:7535969-Animals,
pubmed-meshheading:7535969-Anticonvulsants,
pubmed-meshheading:7535969-Brain,
pubmed-meshheading:7535969-Citalopram,
pubmed-meshheading:7535969-Disease Models, Animal,
pubmed-meshheading:7535969-Epilepsy,
pubmed-meshheading:7535969-Hydroxyindoleacetic Acid,
pubmed-meshheading:7535969-Injections, Intraperitoneal,
pubmed-meshheading:7535969-Mice,
pubmed-meshheading:7535969-Mice, Neurologic Mutants,
pubmed-meshheading:7535969-Monoamine Oxidase,
pubmed-meshheading:7535969-Serotonin,
pubmed-meshheading:7535969-Time Factors,
pubmed-meshheading:7535969-Tryptophan Hydroxylase
|
pubmed:year |
1994
|
pubmed:articleTitle |
Chronic administration of citalopram inhibited El mouse convulsions and decreased monoamine oxidase-A activity.
|
pubmed:affiliation |
Department of Neuroscience, Okayama University Medical School, Japan.
|
pubmed:publicationType |
Journal Article
|